spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Teva Pharmaceutical Industries 

 HSMN NewsFeed - 15 May 2024
Compugen Appoints David Silberman as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Jun 2022
EYLEA(R) (aflibercept) Injection sBLA for Every 16-week Dosing Regimen in Patients with Diabetic Retinopathy Accepted for FDA Review
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Oct 2021
FDA Expands Approval of Dupixent(R) (dupilumab) to Include Children Aged 6 to 11 Years with Moderate-to-severe Asthma
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Feb 2021
The Lancet Publishes Libtayo(R) (cemiplimab) Data Showing Extended Overall Survival in Patients with First-line Advanced Non-small Cell Lung Cancer with PD-L1 Expression of ≥50%
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Aug 2020
FDA Accepts Evinacumab Biologics License Application for Priority Review as a Treatment for Patients with HoFH, an Ultra-rare Inherited Form of High Cholesterol
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 19 Jun 2020
Dupixent(R) (dupilumab) Approved in China for Adults with Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 5 Nov 2019
Regeneron Provides Updates on Phase 3 Libtayo(R) (cemiplimab) Development Program in Advanced Non-small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Aug 2019
Regeneron Announces Positive Topline Results from Phase 3 Trial of Evinacumab in Patients with Severe, Inherited Form of High Cholesterol
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 13 Aug 2019
FDA Approves EYLEA(R) (aflibercept) Injection Prefilled Syringe
Biopharmaceuticals Drug Delivery Ophthalmology FDA
 HSMN NewsFeed - 6 Aug 2019
Dupixent(R) (dupilumab) Approved by European Commission for Adolescents with Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 9 May 2019
MiMedx Appoints Timothy R. Wright as Chief Executive Officer
Devices Wound Care Personnel
 HSMN NewsFeed - 7 May 2019
Dupixent(R) (dupilumab) Approved for Severe Asthma by European Commission
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Mar 2019
Lannett Enters Into Distribution Agreement For Generic Adderall(R)
Biopharmaceuticals Generics Distribution
 HSMN NewsFeed - 1 Mar 2019
CHMP Recommends Approval of Dupixent(R) (dupilumab) for Asthma Indication
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 4 Feb 2019
CHMP Recommends Approval of Praluent(R) (alirocumab) Injection to Reduce Cardiovascular Risk in People with Established Atherosclerotic Cardiovascular Disease
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 25 Oct 2018
89Bio Launches into Liver and Metabolic Disorders with $60 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 25 Oct 2018
EYLEA(R) (aflibercept) Injection Improves Diabetic Retinopathy and Reduces Vision-Threatening Complications in Phase 3 Trial
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 22 Oct 2018
FDA Approves Asthma Indication for Dupixent(R) (dupilumab)
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Sep 2018
FDA to Review EYLEA (aflibercept) Injection for the Treatment of Diabetic Retinopathy
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 12 Sep 2018
FDA to Review Supplemental Biologics License Application for Praluent(R) (alirocumab)Injection as Potential Treatment to Reduce Major Adverse Cardiovascular Events
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 17 Aug 2018
FDA Approves EYLEA(R) (aflibercept) Injection sBLA in Wet Age-related Macular Degeneration
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 13 Aug 2018
Regeneron Provides Regulatory Update on EYLEA(R) (aflibercept) Injection sBLA in Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 16 May 2018
Positive Phase 3 Trial of DUPIXENT(R) (dupilumab) in Adolescents with Inadequately Controlled Moderate-to-severe Atopic Dermatitis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 1 May 2018
Regeneron and Sanofi to Lower Net Price of Praluent(R) (alirocumab) Injection in Exchange for Straightforward, More Affordable Patient Access for Express Scripts Patients
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 30 Apr 2018
FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Mar 2018
EYLEA(R) (aflibercept) Injection Demonstrates Positive Topline Results in Phase 3 Non-Proliferative Diabetic Retinopathy Trial
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 8 Mar 2018
BrainStorm Announces Operational Highlights and Financial Results for the Year Ended December 31, 2017
Regenerative Medicine Neurology
 HSMN NewsFeed - 2 Mar 2018
FDA to Review DUPIXENT(R) (dupilumab) as Potential Treatment for Moderate-to-Severe Asthma
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Feb 2018
Sandoz announces US FDA approval and launch of Glatopa(R) 40 mg/mL three times-a-week generic option for relapsing forms of multiple sclerosis
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 22 Jan 2018
Regeneron Announces Approval of DUPIXENT(R) (dupilumab) in Japan for the Treatment of Atopic Dermatitis
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 11 Dec 2017
Regeneron Announces FDA Acceptance of sBLA Filing for 12-Week Dosing of EYLEA(R) (aflibercept) Injection for Patients with Wet AMD
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 27 Nov 2017
Regeneron Provides Update on EYLEA(R) (aflibercept) Injection and Nesvacumab (Ang2 Antibody) Combination Program
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 2 Nov 2017
BrainStorm Strengthens Executive Team: Appoints Eyal Rubin as Chief Financial Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 28 Sep 2017
Regeneron and Sanofi Announce Approval of DUPIXENT(R) (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis in the European Union
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 8 Sep 2017
Regeneron and Sanofi Announce Cemiplimab (REGN2810) Has Received FDA Breakthrough Therapy Designation for Advanced Cutaneous Squamous Cell Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 25 Aug 2017
Regeneron and Sanofi to Present New Analyses from Praluent(R) (alirocumab) Injection Trials at the ESC Congress 2017
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 14 Aug 2017
Regeneron to Discontinue Development of Suptavumab for Respiratory Syncytial Virus
Biopharmaceuticals
 HSMN NewsFeed - 8 May 2017
Regeneron and Inovio Enter Immuno-Oncology Clinical Study Agreement for Glioblastoma Combination Therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Apr 2017
Regeneron and Sanofi Announce Kevzara(R) (sarilumab) Biologics License Application Resubmission Accepted for Review by U.S. FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Apr 2017
Sanofi and Regeneron Announce FDA Approval of a New Once-Monthly Dosing Option for Praluent(R) (alirocumab) Injection
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 4 Apr 2017
Teva Announces FDA Approval of AUSTEDO(TM) (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington’s Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 28 Mar 2017
Sanofi and Regeneron Announce FDA Approval of Dupixent(R) (dupilumab), the First Targeted Biologic Therapy for Adults with Moderate-to-Severe Atopic Dermatitis
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 6 Mar 2017
Recro Pharma Appoints Bryan Reasons to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Feb 2017
Appeals Court Grants Stay of Permanent Injunction for Praluent(R) (alirocumab) During Appeals Process
Biopharmaceuticals Cardiology Litigation
 HSMN NewsFeed - 7 Feb 2017
Teva Appoints Dr. Yitzhak Peterburg as Interim Chief Executive Officer, Succeeding Erez Vigodman
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 19 Dec 2016
Fibrocell Announces Leadership Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Nov 2016
Gamida Cell Names Julian Adams, Ph.D. New Chairman of the Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 31 Oct 2016
Antares Pharma Appoints Fred M. Powell, Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Oct 2016
Teva Receives Positive Opinion from European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) to Extend Indication of Trisenox(R) for First Line Treatment of Low- to Intermediate Risk Acute Promyelocytic Leukemia (APL)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 6 Oct 2016
Teva and Celltrion Announce Exclusive Biosimilar Commercial Partnership
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Sep 2016
Teva Strengthens Injectables Portfolio with the Launch of an Authorized Generic of Cubicin(R) (Daptomycin for Injection) in the United States
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 5 Aug 2016
Teva Announces Launch of Generic Gleevec(R) Tablets in the United States
Biopharmaceuticals Generics Oncology Product Launch
 HSMN NewsFeed - 3 Aug 2016
Allergan Announces Sale of Anda Distribution Business to Teva Pharmaceutical
Biopharmaceuticals Distribution Acquisitions
 HSMN NewsFeed - 22 Jul 2016
VIVUS Announces Favorable Markman Ruling in Qsymia(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 6 Jul 2016
NeuroDerm Announces Additions to Management Team
Biopharmaceuticals Devices Neurology Personnel
 HSMN NewsFeed - 7 Apr 2016
Cipher Pharmaceuticals Proposes Adding Rosemary A. Crane and Dr. Renee P. Tannenbaum To Board of Directors
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 24 Feb 2016
Alexza Pharmaceuticals Reacquires U.S. Commercial Rights for ADASUVE(R) (loxapine) inhalation powder
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 26 Jan 2016
Antares Pharma Announces CEO Transition
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Dec 2015
Antares Pharma Announces FDA Approval of Sumatriptan Injection USP
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Dec 2015
Teva Pharmaceuticals and Eagle Pharmaceuticals Announce FDA Approval of BENDEKA(TM) (bendamustine hydrochloride) Injection
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 30 Nov 2015
Teva and Takeda Establish Unique Partnership to Meet the Wide-Ranging Needs of Patients and Growing Importance of Generic Medicines Use in Japan
Biopharmaceuticals Generics
 HSMN NewsFeed - 10 Nov 2015
Teva Canada Announces the Launch of PrTeva-Moxifloxacin Tablet, a generic of PrAvelox(R)
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 29 Oct 2015
Allergan plc Confirms Discussions Regarding Potential Business Combination Transaction With Pfizer Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Oct 2015
Teva Announces Exclusive Launch of Generic Avodart(R) Capsules in the United States
Biopharmaceuticals Urology Generics Product Launch
 HSMN NewsFeed - 28 Sep 2015
Teva Announces Approval of COPAXONE(R) in Japan for the Prevention of Relapse of Multiple Sclerosis
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 25 Aug 2015
Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jul 2015
Antares Pharma Appoints Peter J. Graham, Esq., Senior Vice President, General Counsel, Human Resources, Chief Compliance Officer and Corporate Secretary
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Apr 2015
Ovid Therapeutics Appoints Dr. Jeremy Levin as Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 1 Apr 2015
Teva Announces FDA Approval of ProAir(R) RespiClick
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 18 Nov 2014
Antares Pharma Appoints James E. Fickenscher, Senior Vice President, Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Sep 2014
Antares Pharma Announces Promotion of Robert F. Apple to Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Sep 2014
Successful Completion of Phase III Program for Teva’s Reslizumab Two More Phase Iii Studies Support the Benefits of Reslizumab Treatment in Asthma Patients with Eosinophilia
Biopharmaceuticals
 HSMN NewsFeed - 7 Aug 2014
OncoGenex Pharmaceuticals Announces Appointment of John A. Bencich as Vice President and Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 May 2014
Teva Received FDA Approval for QVAR(R) (beclomethasone dipropionate HFA) with Dose Counter
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Apr 2014
Teva Receives European Marketing Authorization for DuoResp Spiromax(R) for the Treatment of Asthma and COPD
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 17 Apr 2014
Teva Settles Patent Litigation with Pfizer on Celebrex(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 4 Mar 2014
Teva Announces Approval of Generic Evista(R) Tablets 60 mg in the United States
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 21 Feb 2014
Teva Completes Tender Offer for NuPathe Inc. Shares
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 21 Feb 2014
Teva Receives CHMP Positive Opinion for DuoResp(R) Spiromax(R) for the Treatment of Patients Diagnosed with Asthma and COPD in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 28 Jan 2014
Teva Announces U.S. FDA Approval of Three-Times-a-Week COPAXONE(R) (glatiramer acetate injection) 40mg/mL
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 21 Jan 2014
NuPathe Terminates Agreement With Endo and Enters Into Agreement to Be Acquired by Teva
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 15 Jan 2014
Antares Pharma Announces Availability of OTREXUP (Methotrexate) Injection for Subcutaneous Use to Treat Rheumatoid Arthritis (RA) and Psoriasis in Adults, and Polyarticular Idiopathic Arthritis (pJIA) in Children
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 9 Jan 2014
Teva Names Erez Vigodman as President and CEO
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 3 Jan 2014
Teva Announces Launch of Authorized Generic of Detrol(R)
Biopharmaceuticals Generics Urology Product Launch
 HSMN NewsFeed - 19 Nov 2013
Antares Pharma Appoints David H. Bergstrom Ph.D. as Senior Vice President Pharmaceutical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Oct 2013
Teva Announces Departure of President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Oct 2013
Teva Announces FDA Approval of Generic TOBI(R) in the United States
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 10 Oct 2013
Teva Accelerates Cost Reduction Program
Biopharmaceuticals
 HSMN NewsFeed - 20 Sep 2013
Teva Announces Exclusive Launch of Generic NIASPAN(R) in the United States
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 19 Aug 2013
TetraLogic Pharmaceuticals Announces New Executives
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Aug 2013
Teva Pharmaceutical And Perrigo Company Announce The U.S. Launch Of Generic Temozolomide
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 12 Jun 2013
Teva Reaches Settlement Agreement with Pfizer and Nycomed Regarding Generic Protonix(R) (Pantoprazole) Tablets
Biopharmaceuticals Litigation
 HSMN NewsFeed - 12 Jun 2013
Pfizer Obtains $2.15 Billion Settlement from Teva and Sun for Infringement of Protonix(R) Patent
Biopharmaceuticals Litigation
 HSMN NewsFeed - 3 Jun 2013
Teva’s Lonquex(R)(XM22 lipegfilgrastim) Recommended for Approval in the EU for the Reduction of Chemotherapy-Induced Neutropenia (CIN)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 8 May 2013
Teva and Alexza Announce Teva’s License to Market ADASUVE(R) in the U.S.
Biopharmaceuticals Licensing
 HSMN NewsFeed - 29 Apr 2013
Teva Expands Management Team with Appointment of Paul J. Sekhri as Group Executive Vice President, Global Business Development and Chief Strategy Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Apr 2013
Teva Establishes Global Specialty Medicines Group
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2013
Ambit Biosciences Appoints David Parkinson, M.D., to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Apr 2013
Teva Names Ichiro Kikushige as CEO of Teva Seiyaku, Japan
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Mar 2013
FDA Approves New Drug Application (NDA) for Teva’s Quartette(TM) (levonorgestrel/ethinyl estradiol and ethinyl estradiol) Tablets for the Prevention of Pregnancy
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Dec 2012
Galena Biopharma Announces Signature of Commercialization Partnership With Teva for Israel
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Nov 2012
Antares Pharma Announces Positive Results from Final MTX Medi-Jet(TM) Clinical Study
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 5 Nov 2012
Teva Announces Changes to Executive Leadership Team
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 26 Oct 2012
Teva Receives Approval For SYNRIBO(TM) (Omacetaxine Mepesuccinate) for Injection
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Sep 2012
Bayer HealthCare To Acquire U.S. Animal Health Business From Teva Pharmaceutical Industries
Biopharmaceuticals
 HSMN NewsFeed - 13 Sep 2012
Teva Pharmaceutical Announces the Appointment of Professor Itzhak Krinsky as Chairman of Teva Japan and Teva South Korea and Head of Business Development in Asia-Pacific
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Aug 2012
Teva Announces FDA Grants Approval for Tbo-filgrastim for the Treatment of Chemotherapy-Induced Neutropenia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 13 Aug 2012
Teva Receives FDA Acceptance of Its New Drug Application for Quartette(TM) (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets) for the Prevention of Pregnancy
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Aug 2012
Teva Pharmaceutical Announces New Appointments of President and Chief Executive Officer, Global Operations and Executive Vice President, Community and Institutional Affairs
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 2 Jul 2012
Antares Pharma Appoints Jonathan S. Jaffe MD Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jun 2012
Teva Announces Favorable Court Ruling in COPAXONE(R) Patent Infringement Litigation
Biopharmaceuticals Generics Neurology Litigation
 HSMN NewsFeed - 15 Jun 2012
ViaCyte Appoints Dr. Paul Laikind Chief Executive Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 5 Apr 2012
FDA Decides Teva is Sole First-to-File on Provigil(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 1 Jan 2012
Teva Announces Management Succession
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Dec 2011
Dr. Rob Koremans to succeed Dr. Gerard van Odijk as President and CEO of Teva Europe
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Dec 2011
Antares' Oxybutynin Gel Product Approved by FDA for the Treatment of Overactive Bladder
Biopharmaceuticals Drug Delivery Urology FDA
 HSMN NewsFeed - 14 Oct 2011
Teva Completes Acquisition of Cephalon
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 4 Aug 2011
Antares Pharma Announces Positive Study Results with VIBEX(TM) MTX in Rheumatoid Arthritis Patients
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 11 Jul 2011
Watson and Antares Announce Exclusive License Agreement for Antares' Oxybutynin Gel Product (Anturol(R))
Biopharmaceuticals Licensing
 HSMN NewsFeed - 16 May 2011
Teva to Acquire Taiyo
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 8 Apr 2011
Antares Pharma Announces FDA Acceptance of Anturol(R) NDA for Filing
Biopharmaceuticals Urology
 HSMN NewsFeed - 26 Jan 2011
Teva to Acquire Corporación Infarmasa
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Jan 2011
APP Pharmaceuticals Announces Agreement with Teva Pharmaceuticals to Manufacture and Market Gemcitabine HCI for Injection
Biopharmaceuticals Licensing Oncology
 HSMN NewsFeed - 5 Jan 2011
Teva Completes Acquisition of Théramex
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Dec 2010
Teva Announces Successful Results of Phase III Study with Oral Laquinimod for Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Dec 2010
Teva Comments on Patent Infringement Lawsuit Filed by Momenta and Sandoz
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 2 Dec 2010
Momenta Pharmaceuticals Sues Teva for Patent Infringement
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 28 Sep 2010
Tigris Pharmaceuticals Appoints Neil Flanzraich to Executive Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Sep 2010
Court Denies Sandoz/Momenta's Summary Judgment of Invalidity in Copaxone(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 7 Sep 2010
Protalix BioTherapeutics Names Tzvi Palash Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Aug 2010
Teva Completes Acquisition of ratiopharm
Biopharmaceuticals Mergers & Acquisitions Generics
 HSMN NewsFeed - 22 Jul 2010
EKR Therapeutics Names New Executive Team to Lead Company Growth in Critical Care Products Sector of Hospital Marketplace
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Jul 2010
Teva Provides Update on Generic Protonix(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 29 Jun 2010
Teva Announces Approval of Generic Effexor XR(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 23 Jun 2010
Spectrum Pharmaceuticals Appoints James E. Shields as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jun 2010
Teva Announces Positive Results from a Study Assessing a New Formulation of Copaxone(R)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Jun 2010
Teva Announces Launch of Generic Differin(R)
Biopharmaceuticals Generics Dermatology FDA
 HSMN NewsFeed - 18 May 2010
Teva Reaches Settlement Agreement With AstraZeneca Regarding Generic Entocort(R) EC Capsules
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 17 May 2010
Teva Provides Update on Talampanel for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 14 May 2010
Teva Announces Tentative Approval of Generic Sensipar(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 28 Apr 2010
Teva Announces Launch of Generic Flomax(R)
Biopharmaceuticals Generics Urology FDA
 HSMN NewsFeed - 28 Apr 2010
Takeda Provides Update on Patent Litigation for ACTOS(R) (pioglitazone HCl) and ACTOplus met(R) (pioglitazone HCl and metformin HCl) in the U.S.
Biopharmaceuticals Litigation Endocrinology
 HSMN NewsFeed - 23 Apr 2010
Teva Provides Update on Generic Protonix(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 23 Apr 2010
INTUNIV(TM) - Shire Files Suit Against Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries, Ltd.
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 7 Apr 2010
Teva Announces Final Approval of Generic Hyzaar(R) and Cozaar(R)
Biopharmaceuticals Generics Cardiology FDA
 HSMN NewsFeed - 1 Apr 2010
Teva Settles Generic Eloxatin Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 25 Mar 2010
Teva Announces Tentative Approval of Generic Argatroban(R) Injection
Biopharmaceuticals Cardiology Generics FDA
 HSMN NewsFeed - 18 Mar 2010
Teva to Acquire ratiopharm
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 9 Mar 2010
Teva Announces the Appointment of Dr. Philip Frost as Chairman of Its Board of Directors
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 2 Mar 2010
Teva Announces Favorable Court Ruling in Generic Hyzaar(R) and Cozaar(R) Litigation
Biopharmaceuticals Litigation Generics Cardiology
 HSMN NewsFeed - 25 Feb 2010
Copaxone(R) 15-Year Study in Multiple Sclerosis Patients Demonstrates Robust Long-Term Efficacy and Safety
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Feb 2010
Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma
Regenerative Medicine Oncology
 HSMN NewsFeed - 5 Feb 2010
Teva Announces Settlement in Principle regarding Certain Drug Pricing Lawsuits
Biopharmaceuticals Litigation
 HSMN NewsFeed - 29 Jan 2010
Teva UK Limited Launches Lercanidipine Hydrochloride Film-Coated Tablets
Biopharmaceuticals Generics
 HSMN NewsFeed - 28 Jan 2010
Teva UK Limited Launches Dorzolamide 2% Eye Drops Solution
Biopharmaceuticals Generics Ophthalmology
 HSMN NewsFeed - 22 Jan 2010
Biovail Comments on Proposed Generic Wellbutrin XL(R) Trial
Biopharmaceuticals Generics
 HSMN NewsFeed - 21 Jan 2010
Teva Announces Tentative Approval of Generic Femara(R) Tablets
Biopharmaceuticals Generics Oncology FDA
 HSMN NewsFeed - 8 Jan 2010
Watson Files FDA Application for Generic LoSeasonique(R)
Biopharmaceuticals Generics FDA Litigation
 HSMN NewsFeed - 7 Jan 2010
Teva Announces Settlement Agreements with AstraZeneca Regarding Generic Prilosec(R) and Nexium(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 24 Dec 2009
Teva-KOWA Pharma to Acquire a Majority Share Interest in Taisho Pharmaceutical Industries
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Dec 2009
Teva Expands Innovative Pipeline with License Agreement to Develop and Commercialize OncoGenex' Late Stage Innovative Treatment for Multiple Oncology Indications
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 11 Dec 2009
Trial Date Set for CUBICIN(R) Patent Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 10 Nov 2009
Teva Receives Favorable Court Decision Regarding Generic Prevacid(R) SoluTab
Biopharmaceuticals Generics Drug Delivery Litigation
 HSMN NewsFeed - 26 Sep 2009
Teva Provides Update on Generic Seroquel(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 24 Sep 2009
Teva Provides Update on Generic Evista(R) Litigation
Biopharmaceuticals Generics Oncology Litigation
 HSMN NewsFeed - 16 Sep 2009
Plan B(R) One-Step Emergency Contraception Now Available At U.S. Pharmacies
Biopharmaceuticals
 HSMN NewsFeed - 10 Sep 2009
COPAXONE(R) Significantly Reduced Disease Severity in Long-Term Treated Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 19 Aug 2009
Teva Provides Update on Generic Singulair(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 11 Aug 2009
Teva Announces Approval and Launch of Oxaliplatin Injection
Biopharmaceuticals Generics Oncology FDA
 HSMN NewsFeed - 3 Aug 2009
Perrigo Announces FDA Approval for Generic Version of NASACORT(R) AQ
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 17 Jul 2009
Teva Provides Update on Generic Ortho Tri-Cyclen(R) Lo
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 1 Jul 2009
Teva Announces Approval and Launch of Tri-Lo Sprintec Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 29 Jun 2009
Teva and Antares Announce FDA Approval of Needle-Free Injector Product for Administration of Tev-Tropin(R) (Human Growth Hormone)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 6 May 2009
Teva Announces Extension of Patent Protection for Azilect
Biopharmaceuticals Neurology Generics
 HSMN NewsFeed - 28 Apr 2009
Long-Term Study with COPAXONE Indicated Protective Effect on Brain Tissue in Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Apr 2009
Teva Introduces First Generic Adderall XR Capsules in the United States
Biopharmaceuticals Generics
 HSMN NewsFeed - 1 Apr 2009
Teva Announces Approval of Generic Yaz Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 27 Mar 2009
Teva Announces Approval and Launch of Generic Topamax Tablets
Biopharmaceuticals Neurology FDA Generics
 HSMN NewsFeed - 10 Feb 2009
Teva Announces Approval and Launch of Generic Imitrex(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 4 Feb 2009
COPAXONE(R) is Approved for Treatment of Patients with a First Clinical Event Suggestive of Multiple Sclerosis
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 30 Jan 2009
Teva Announces Approval of Generic Risperdal(R) Oral Solution
Biopharmacueticals Generics FDA
 HSMN NewsFeed - 23 Jan 2009
IMPAX Receives Final FDA Approval for Omeprazole 40 mg Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 25 Nov 2008
Watson Enters Into Agreement to Acquire Products Related to Teva's Proposed Acquisition of Barr
Biopharmaceuticals Acquisitions Generics
 HSMN NewsFeed - 20 Nov 2008
Teva Provides Update on Generic Pulmicort Respules® Launch
Biopharmaceuticals Generics
 HSMN NewsFeed - 27 Oct 2008
FDA Approves Duramed's LoSEASONIQUE(R) Oral Contraceptive
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Sep 2008
Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering
Biopharmaceuticals Licensing
 HSMN NewsFeed - 25 Sep 2008
IVAX Diagnostics Announces Appointment of Paul F. Kennedy as Chief Executive Officer, President and Chairman of the Board
Diagnostics Personnel
 HSMN NewsFeed - 23 Sep 2008
US Court Denies Teva's Motion for Summary Judgment in PULMICORT RESPULES(R) Patent Litigation
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 22 Sep 2008
Teva Introduces Nicardipine HCl Injection in the United States; First Alternative to Cardene(R) I.V.
Biopharmaceuticals Generics Cardiology
 HSMN NewsFeed - 18 Sep 2008
Laquinimod Demonstrated Significant and Sustained Impact on Multiple Sclerosis Disease Activity
Biopharmaceuticals Neurology
 HSMN NewsFeed - 18 Sep 2008
Longest Prospective Study in MS Confirmed Robust Clinical Benefits and Safety of COPAXONE(R)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 16 Sep 2008
Teva Receives EU Marketing Authorization for TevaGrastim(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 26 Aug 2008
ADAGIO Trial Results Show Teva's AZILECT(R) 1 mg Tablets Slow Progression of Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 20 Aug 2008
Barr Announces Approval of Generic Aredia(R) Injection, 30mg/mL, 60mg/mL and 90mg/mL Injectable
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 5 Aug 2008
Panacea Pharmaceuticals Announces Appointment of Suzanne Sensabaugh as Vice President, Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jul 2008
Teva Completes Acquisition of Bentley Pharmaceuticals
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 18 Jul 2008
Teva to Acquire Barr
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Jul 2008
Teva Enrolls Patients for a Second Large Global Phase III Trial of Oral Laquinimod
Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 Jul 2008
Teva Comments on Paragraph IV Filing for COPAXONE(R); Intends to File Lawsuit against Generic Filer for Patent Infringement
Biopharmaceuticals Generics Neurology FDA Litigation
 HSMN NewsFeed - 11 Jul 2008
Momenta Pharmaceuticals Announces Filing of Abbreviated New Drug Application With a Paragraph IV Certification for Generic Version of Copaxone
Biopharmaceuticals Generics Neurology FDA
 HSMN NewsFeed - 1 Jul 2008
Teva Provides Update on Generic Seroquel(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 1 Jul 2008
Bentley Pharmaceuticals Completes Spin-off of Drug Delivery Business
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 12 Jun 2008
Teva Announces Tentative Approval of Generic Diovan(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 May 2008
Teva Announces Launch of Generic Wellbutrin XL(R) Tablets, 150 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 Apr 2008
Teva Announces Global In-Market First Quarter Sales of Copaxone(R) Increased 35% to $542 Million
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 Apr 2008
Teva Announces Approval of Generic Flolan(R) for Injection
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 17 Apr 2008
Teva Announces Tentative Approval of Generic Maxalt(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 10 Apr 2008
COPAXONE(R) Significantly Reduced Annual Relapse Rates and Stabilized Disease Progression in Relapsing Remitting Multiple Sclerosis Patients Failing Interferon Treatment
Biopharmaceuticals Neurology
 HSMN NewsFeed - 31 Mar 2008
Teva Provides Update on Generic Prevacid(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 31 Mar 2008
Teva to Acquire Bentley Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Mar 2008
Teva Provides Update on Generic Aricept(R) Litigation
Biopharmaceuticals Generics Litigation Neurology
 HSMN NewsFeed - 13 Mar 2008
Teva Provides Update on Glatiramer Acetate 40mg for Amyotrophic Lateral Sclerosis (ALS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 29 Feb 2008
Teva Provides Update on Generic Actonel(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 28 Feb 2008
Teva Announces Approval of Generic Camptosar(R)
Biopharmaceuticals Generics Oncology FDA
 HSMN NewsFeed - 25 Feb 2008
Teva Announces Two Court Decisions to Revoke MSD's European Patent on Generic Fosamax(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 6 Feb 2008
Teva Announces Approval of Generic Fosamax(R) Tablets, 5 mg, 10 mg, 35 mg, 40 mg and 70 mg
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 1 Feb 2008
Teva Provides Update on Generic Protonix(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 31 Jan 2008
Teva Announces Tentative Approval of Generic Flomax(R) Capsules
Biopharmaceuticals Urology Generics FDA
 HSMN NewsFeed - 30 Jan 2008
Medical Ventures to Acquire Two Vascular Device Developers
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 30 Jan 2008
Caraco Pharmaceutical Laboratories Ltd. to Market Generic Protonix(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 29 Jan 2008
Teva Announces Wyeth Voids Standstill Agreement on Generic Protonix(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 23 Jan 2008
Teva Announces Tentative Approval of Generic Prevacid(R) Delayed-Release Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 22 Jan 2008
Teva to Acquire CoGenesys
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Jan 2008
Teva Specialty Pharmaceuticals and UCB Announce U.S. Respiratory Collaboration Agreement
Biopharmaceuticals
 HSMN NewsFeed - 14 Jan 2008
Teva Announces Tentative Approval of Generic Aricept(R) Tablets
Biopharmaceuticals Generics FDA Neurology
 HSMN NewsFeed - 14 Jan 2008
Teva to Explore Strategic Alternatives for its Animal Health Business
Biopharmaceuticals
 HSMN NewsFeed - 10 Jan 2008
Teva Announces Departure of North American CEO William S. Marth to Become CEO of Teva North America
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2008
Antares Pharma Develops Novel Pen Injector under New Agreement with Teva Pharmaceuticals
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 3 Jan 2008
IVAX Diagnostics Announces Resignation of President and Chief Executive Officer
Diagnostics Personnel
 HSMN NewsFeed - 3 Jan 2008
Teva Announces Approval of Generic Kytril(R) Injection and Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 2 Jan 2008
Teva Announces Approval of Generic DuoNeb
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 24 Dec 2007
Teva Announces Launch of Generic Protonix(R) Tablets, 20 mg and 40 mg
Biopharmaceuticals Generics
 HSMN NewsFeed - 12 Dec 2007
Teva Announces Approval of Generic Trileptal(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 12 Dec 2007
Lannett Receives FDA Approval for Phentermine
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 3 Dec 2007
Early Treatment with COPAXONE(R) Demonstrated Robust Protection against Progression to Clinically Definite Multiple Sclerosis in the PreCISe Study
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Nov 2007
Teva Announces Tentative Approval of Generic Requip(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 6 Nov 2007
First Patient Undergoes Expanded Cord Blood Transplant in the ExCell Registration Study of StemEx(R) for Leukemia and Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Oct 2007
Teva Announces Planned Retirement of CFO Dan Suesskind in Mid-2008
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Oct 2007
New Long-Term Analysis of Clinical Treatment Outcomes Demonstrated COPAXONE(R) is More Cost Effective Than Tysabri(R) for Treatment of Relapsing-Remitting Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 25 Oct 2007
Study Showed Patients Using COPAXONE(R) Had Significantly Lower Risk of Relapse and Lower Medical Costs Compared to Patients Using Rebif(R) in Relapsing-Remitting Multiple Sclerosis (RRMS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 Oct 2007
COPAXONE(R) Significantly Decreases Disease Activity in Patients Who Switched from Interferon Beta (IFNb) Due to Development of Neutralizing Antibodies (NAbs)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 22 Oct 2007
Adenoscan(R) Patent Lawsuits Settled
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 12 Oct 2007
Long-Term Study Shows COPAXONE(R) Significantly Slows Progression of Disability and Reduces Relapse Rates in Patients with Relapsing-Remitting Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Oct 2007
Teva Announces Approval of Generic Actonel(R)
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 5 Oct 2007
Teva Announces Tentative Approval of Generic Valtrex(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 27 Sep 2007
Teva Announces Settlement of Generic Avandia(R), Avandamet(R), and Avandaryl(R) Litigation with GlaxoSmithKline
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 20 Sep 2007
IVAX Diagnostics Appoints Kevin D. Clark Chief Operating Officer
Diagnostics Personnel
 HSMN NewsFeed - 19 Sep 2007
Teva Provides Update on Edratide for Systemic Lupus Erythematosus
Biopharmaceuticals
 HSMN NewsFeed - 19 Sep 2007
Teva Receives Positive Feedback on Second AOK Tender in Germany
Biopharmaceuticals
 HSMN NewsFeed - 16 Sep 2007
Teva Announces Appointment of Isaac Abravanel as Corporate Vice President, Human Resources
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Sep 2007
Teva Provides Update on Generic Famvir(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 7 Sep 2007
Teva Announces Launch of Generic Famvir(R) Tablets
Biopharmaceuticals Generics
 HSMN NewsFeed - 6 Sep 2007
Teva Receives Favorable Court Decision Regarding Generic Protonix(R) Tablets; Motion for Preliminary Injunction Denied
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 6 Sep 2007
Aradigm and CyDex Sign Development Collaboration Agreement
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 6 Sep 2007
Teva Announces Approval and Shipment of Generic Coreg(R) Tablets
Biopharmaceuticals Cardiology Generics FDA
 HSMN NewsFeed - 5 Sep 2007
Teva Receives Favorable Court Decision Regarding Generic Famvir(R) Tablets; Novartis' Motion for Preliminary Injunction Denied
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 24 Aug 2007
Teva Announces Approval of Generic Famvir(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 10 Aug 2007
Teva Announces Tentative Approval of Sildenafil Citrate Tablets, 20 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 10 Aug 2007
Teva Announces Approval of Epirubicin Hydrochloride Injection
Biopharmaceuticals Generics Oncology FDA
 HSMN NewsFeed - 2 Aug 2007
Teva Announces Approval of Generic Protonix(R) Delayed Release Tablets, 20 mg and 40 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 29 Jun 2007
Teva Announces Approval of Amlodipine Besylate Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 28 Jun 2007
Teva Announces Tentative Approval of Famciclovir Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 26 Jun 2007
Teva Announces Approval of Ondansetron HCl Tablets and Ondansetron Orally Disintegrating Tablets USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 12 Jun 2007
BioSante Pharmaceuticals Announces Reinitiation of Product Development With Teva
Biopharmaceuticals
 HSMN NewsFeed - 11 Jun 2007
Teva Receives Favorable Court Decision Regarding Generic Lotrel(R); Novartis' Motion for Preliminary Injunction Denied
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 8 Jun 2007
International Movement Disorder Specialists Receive New Information About the Use of Once-Daily AZILECT(R) in the Treatment of Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 7 Jun 2007
Teva and Active Biotech to Initiate Pivotal Phase III Trial Program of Oral Laquinimod for Relapsing Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 6 Jun 2007
COPAXONE(R) Pre-Filled Syringe Can Now Be Stored for up to One Month at Room Temperature
Biopharmaceuticals FDA Neurology
 HSMN NewsFeed - 1 Jun 2007
IMPAX Announces Decision on Generic Prilosec(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 1 Jun 2007
Genomic Health Announces Exclusive Distribution Agreement for Oncotype DX Breast Cancer Assay in United Kingdom
Diagnostics Distribution Oncology
 HSMN NewsFeed - 29 May 2007
US Court Continues to Prevent Teva From Shipping Any Additional Generic Copies of the High Blood Pressure Medicine Lotrel
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 21 May 2007
Teva Provides Update on Generic Lotrel(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 20 May 2007
Teva Provides Update on Generic Lotrel(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 13 May 2007
Teva Comments About the Acquisition of Merck KGaA Generic Business
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 10 May 2007
Teva Announces Approval and Shipment of Generic Omnicef(R) Capsules and POS
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 9 May 2007
IMPAX Receives Final FDA Approval for Generic Ditropan(R) XL 5 mg and 10 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 8 May 2007
Teva Announces Tentative Approval of Generic Gemzar(R) for Injection
Biopharmaceuticals Generics Oncology FDA
 HSMN NewsFeed - 4 May 2007
Treatment with COPAXONE(R) Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 4 May 2007
COPAXONE(R) Treatment over Two Years after Short Term Induction with Mitoxantrone Provided Sustained Benefits to Active Relapsing-Remitting Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 1 May 2007
Laquinimod, a Novel Oral Compound, Showed Significant Reduction in Disease Activity in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 17 Apr 2007
Data Published in Neurology Showed That Higher Dose of COPAXONE(R) Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 Apr 2007
First Pharmacoeconomic Analysis with Long-Term Data Showed COPAXONE(R) Was More Cost-Effective Than Interferon Beta Therapies for Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 21 Mar 2007
Teva Provides Update on Generic Celebrex(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 9 Mar 2007
Teva Receives First U.S. Approval for Generic Uniretic(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 8 Mar 2007
Teva Receives Approval for Generic Dostinex(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 7 Mar 2007
Teva Announces the Office of the Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Mar 2007
IMPAX Settles Patent Litigation Related to Generic Wellbutrin(R) XL
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 5 Mar 2007
Teva Announces Agreement with Biovail and Anchen Regarding Generic Wellbutrin XL
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 5 Mar 2007
Biovail Announces Comprehensive Settlement Related to Wellbutrin XL(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 1 Mar 2007
Teva Announces Approval of Alprazolam ER Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 27 Feb 2007
Vaccinex Announces Antibody Development and Commercialization Alliance in Multiple Sclerosis and Oncology
Biopharmaceuticals Neurology
 HSMN NewsFeed - 27 Feb 2007
Post-Hoc Data Analyses Published in Annals of Neurology Found COPAXONE(R) Significantly Delayed Accumulated Disability in Male Patients with Primary Progressive Multiple Sclerosis (PPMS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 22 Feb 2007
Teva Announces Approval of Rabeprazole Sodium Delayed-Release Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 11 Feb 2007
Shlomo Yanai Will Assume the Role of Teva's President& CEO on March 1st, 2007
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jan 2007
Teva Receives Approval for Generic Focalin(TM) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 24 Jan 2007
Teva Files Patent Infringement Complaints Regarding Sertraline Hydrochloride
Biopharmaceuticals Litigation
 HSMN NewsFeed - 22 Dec 2006
Largest Disease Modification Trial for Parkinson's Disease Completes Enrollment
Biopharmaceuticals Neurology
 HSMN NewsFeed - 18 Dec 2006
IMPAX Announces FDA Approval of Generic Wellbutrin XL 300 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 14 Dec 2006
CyDex Announces Captisol Technology Used in Recently Launched Injection Formulation of Antipsychotic Medication ABILIFY(R) (aripiprazole)
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 11 Dec 2006
Synerx Pharma Announces Teva Marketing Partnership
Biopharmaceuticals
 HSMN NewsFeed - 29 Nov 2006
Teva Announces Tentative Approval of Sumatriptan Succinate Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 Nov 2006
Teva Announces Agreement with Pfizer Regarding Idarubicin, Azithromycin, and Epirubicin
Biopharmaceuticals Litigation
 HSMN NewsFeed - 15 Nov 2006
Ambrilia Announces European Licensing Partnership with TEVA for its Lead Oncology Product, Octreotide
Biopharmaceuticals Licensing
 HSMN NewsFeed - 14 Nov 2006
Court of Appeals Affirms Teva's Generic Zocor(R) Exclusivity
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 10 Nov 2006
IMPAX Receives Final FDA Approval and First-to-File Status for Generic Version of Ditropan(R) XL 15 mg
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 6 Nov 2006
Elbit Medical Group Announces Receipt of a Special Protocol Assessment From the FDA to Gamida Cell's Stemex(R) Registration Study
Regenerative Medicine FDA
 HSMN NewsFeed - 2 Nov 2006
Gamida Cell's StemEx(R) Registration Study Receives Special Protocol Assessment from the FDA
Regenerative Medicine FDA
 HSMN NewsFeed - 18 Oct 2006
TEVA Announces Planned Retirement of President & CEO in 2007
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Oct 2006
Teva Announces OxyContin(R) Litigation Dismissed; Settlement with Purdue Finalized
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 12 Oct 2006
Teva Announces Tentative Approval for Generic Risperdal(R) Oral Solution
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 4 Oct 2006
Antares Pharma to Supply Teva with Innovative Needle-Free Injection System
Biopharmaceuticals
 HSMN NewsFeed - 3 Oct 2006
Long-Term Data Demonstrated Significantly Better Patient Adherence to COPAXONE(R) versus Interferons in Multiple Sclerosis Treatment
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Oct 2006
COPAXONE(R) Showed Sustained Benefit on Slowing Brain Tissue Damage in Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 29 Sep 2006
Very Active Multiple Sclerosis Patients Benefited from COPAXONE(R) Treatment Following Short-Term Induction with Mitoxantrone
Biopharmaceuticals Neurology
 HSMN NewsFeed - 29 Sep 2006
Study Showed Significant and Sustained Efficacy Of COPAXONE(R) Alone Following Short-Term Combination Therapy With IV Steroids in Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 Sep 2006
New Data Confirmed Antibodies to COPAXONE(R) do not Impact Its Established and Sustained Long-Term Efficacy in Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 26 Sep 2006
Teva Pharmaceutical Industries Ltd. and Protalix Biotherapeutics Ltd. Announce a Collaboration Agreement for the Development of Two Biopharmaceuticals, Based on Protalix's Recombinant Plant Cell Expression Technology
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 Sep 2006
IMPAX Prevails in Alza's Appeal Related to Generic Version of Ditropan(R) XL
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 20 Jul 2006
Teva Announces Final Approval of Meloxicam Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 18 Jul 2006
Antares Pharma Announces Licensing Agreement with Teva for Novel Injector Device
Biopharmaceuticals Devices Drug Delivery Licensing
 HSMN NewsFeed - 12 Jul 2006
Teva Announces Tentative Approval of Generic Lotrel(R) Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 12 Jul 2006
Teva Will Be Sole Promoter of AZILECT(R) for Parkinson's Disease in the United States
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Jun 2006
Teva Receives FDA Approval for Generic Zoloft(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 27 Jun 2006
Teva Provides Generic Biaxin(R) XL Update
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 23 Jun 2006
Teva Receives First U.S. Approval of Generic Zocor(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 23 Jun 2006
Teva Announces Novartis' Sandoz Unit Seeks to Delay First FDA Approval of Generic Zocor(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 22 Jun 2006
Court of Appeals Rules in Favor of Teva on Biaxin(R) XL Preliminary Injunction
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 31 May 2006
COPAXONE(R) Reduced Relapses and Stabilized Disability as Measured by Expanded Disability Status Scale, When Avonex(R) Failed
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 May 2006
Teva Announces Tentative Approval for Generic Cozaar(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 25 May 2006
Teva Announces Tentative Approval of Simvastatin Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 22 May 2006
Teva Announces Approval of Generic Lexapro(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 17 May 2006
AZILECT(R) FDA Approval Brings New Hope to People Living With Parkinson's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 17 May 2006
Teva Announces FDA Grants Approval of AZILECT(R) (Rasagiline) for Parkinson's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 8 May 2006
Long-Term Copaxone(R) Study Showed 92% of Multiple Sclerosis Patients Were Still Walking Unaided After a Mean of 10 Years on Treatment
Biopharmaceuticals Neurology
 HSMN NewsFeed - 7 May 2006
Teva Announces Approval of Polyethylene Glycol 3350 NF for Oral Solution
Biopharmaceuticals Generics FDA
Return to NewsFeed  

 Additional items found! 219

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 219 additional stories matching:
Teva Pharmaceutical Industries
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.